Pharmacological treatment of primary membranous nephropathy in 2016.

Abstract

INTRODUCTION Therapy in patients with primary membranous nephropathy is debated. The discovery of anti-PLA2R antibodies provides opportunities for new treatment strategies. Areas covered: The PubMed database and Cochrane library were searched for full-text articles published in English before March 2016. The search terms included 'Glomerulonephritis… (More)
DOI: 10.1080/17512433.2016.1225497

Topics

  • Presentations referencing similar topics